Asthma UK’s vision is to stop asthma attacks and cure asthma, and Innovate UK supports UK businesses to develop and commercialise new products and services to tackle some of the biggest global health challenges. Together, they are investing in exceptional patient-centric science and trying to broker research collaborations between academia and UK industry to develop new tools that can accurately diagnose asthma and its subtypes so that 5.4 million people with asthma in the UK can benefit from personalised healthcare.

The focus of this call is to develop tools for quick, accurate, scalable and low-cost diagnostics in asthma. Research can be focussed at any stage of the innovation pathway however, a clear pathway to adoption or commercialisation must be articulated (including estimated timescales), any collaboration with partners who can drive research outputs to adoption/commercialisation must be evidenced, and projects which are likely to achieve impact for people with asthma in the short to medium term (5-10 years) will be prioritised.

They will be awarding grants between £50k and £250k which will be available for up to three years